Facility

ISO 9001, ISO 14001 and ISO 45001 are all being revised, which leaves quality (QMS), environmental (EMS) and occupational health and safety (OH&S) managers, along with top management, with required work ahead to meet the new requirements. Because the revisions put more weight on climate change, resilience, ethics and people-related issues, they are more than…

Artis BioSolutions announced the launch of its Genetics Medicines Center of Excellence in Bilbao, Spain, where it already has a facility specializing in synthetic DNA manufacturing. The company, which also has facilities in Boston and San Diego, supports genetic medicine developers with manufacturing processes. It was cofounded by Harvard University, MIT and Boston research hospitals as Landmark Bio.…

RayzeBio, a subsidiary of Bristol Myers Squibb, announced plans to construct a new $173 million facility in Whitestown, Indiana. The 225,000-square-foot facility will be located at the Anson Industrial Park in Boone County and will manufacture radiopharmaceutical therapies (RPTs). Construction is expected to begin this year. The company currently has a 77,000-square-foot RPT supply and manufacturing facility…

Bristol Myers Squibb (NYSE: BMY) announced it has selected Houston as the site for a new 600,000-square-foot multi-modal manufacturing campus, representing an approximately $2.3 billion investment. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs, the company said.  The campus’ multi-modal capabilities will allow BMS to manufacture multiple types of medicines – such as…

Pharmaceutical manufacturing depends on repeatable inspection. A tablet with a crack, chip, stain, discoloration or other visible anomaly can signal a problem that deserves attention before product moves further downstream. Human inspection remains valuable, but it is inherently variable and difficult to scale consistently across long runs, multiple products and changing operators. Computer vision offers…

A Fujifilm Biotechnologies’ commercial-scale cell culture manufacturing facility has been selected for the FDA’s PreCheck Pilot Program, the company announced. The CDMO’s Holly Springs, North Carolina, facility was selected as one of seven participants in the program designed to strengthen United States pharmaceutical manufacturing capabilities and accelerate patient access to critical medicines. “We are honored…

Healthcare CDMO manufacturer MGS has brought a 300,000 square foot drug delivery device manufacturing facility online in Richfield, Wisconsin. The move expands U.S. production capacity as demand for complex combination products strains available cleanroom capacity . FDA approved a record number of combination products in recent years, and the 505(b)(2) pathway has made device-drug combos…

Fujifilm Biotechnologies recently celebrated the grand opening of its expanded biopharmaceutical CDMO facility in Teesside, U.K. In a Feb. 11 news release, the company said the expansion introduces 2,000 L and 5,000 L single-use bioreactors with a total capacity up to 19,000 L. The goal is to provide small- and mid-scale antibody manufacturing, and there’s…

Pharmaceutical manufacturers face growing pressure to move beyond isolated automation islands. They need fully connected, plant-wide systems instead. Biophorum’s Digital Plant Maturity Model makes it clear: Level 3, the connected plant, is now table stakes to compete. yet many companies still struggle to make the leap. Data stays fragmented across systems. Operator interfaces vary wildly.…

Johnson & Johnson (NYSE:JNJ) is expanding in Wilson County, North Carolina, with a new multibillion-dollar pharmaceutical facility. The company expects to create up to 500 new jobs in the community through the project in Wilson. It marks the second time in 14 months that J&J has announced a significant project in the area after a…